Stockscreener 앱 받기
2.10
0.48%
0.01
시장 영업 전:
2.03
-0.07
-3.33%
전일 마감가:
$2.09
열려 있는:
$2.1
하루 거래량:
48,909
Relative Volume:
0.34
시가총액:
$36.42M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+0.00%
1개월 성능:
+0.48%
6개월 성능:
-23.64%
1년 성능:
-45.74%
1일 변동 폭
$2.09
$2.10
1주일 범위
$2.08
$2.10
52주 변동 폭
$0.95
$4.74
Mural Oncology Plc Stock (MURA) Company Profile
명칭
Mural Oncology Plc
전화
353 1 905 8020
주소
10 EARLSFORT TERRACE, DUBLIN 2
MURA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MURA
Mural Oncology Plc
|
2.10 | 36.21M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.82 | 107.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.32 | 80.03B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.80 | 57.37B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.93 | 55.83B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
209.02 | 44.13B | 447.02M | -1.18B | -906.14M | -6.1812 |
Mural Oncology Plc Stock (MURA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-25 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-25 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2024-06-28 | 개시 | Rodman & Renshaw | Buy |
| 2024-04-04 | 개시 | Morgan Stanley | Overweight |
Mural Oncology Plc 주식(MURA)의 최신 뉴스
Citadel Group discloses 1.38% stake in Mural Oncology By Investing.com - Investing.com South Africa
Form 8.3The Vanguard Group, Inc.: Mural Oncology plc - TradingView
Mural Oncology plc (MURA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Citadel Group discloses 1.32% stake in Mural Oncology - Investing.com
REGCitadel Group Mural Oncology PLCForm 8.3Mural Oncology plc - TradingView
What drives Mural Oncology plc stock priceLow Risk Investment Ideas & Rapid Capital Gain - earlytimes.in
Is Mural Oncology plc stock attractive for ETFsJuly 2025 Weekly Recap & Stock Portfolio Risk Control - newser.com
Why Mural Oncology plc stock remains a top recommendation - newser.com
Will Mural Oncology plc stock benefit from green energy trendsTrade Entry Report & Safe Capital Growth Plans - newser.com
Citadel Group discloses 1.32% stake in Mural Oncology By Investing.com - Investing.com Nigeria
Is Mural Oncology plc stock ready for a breakoutJuly 2025 Chart Watch & Momentum Based Trading Ideas - newser.com
Citadel discloses 1.31% stake in Mural Oncology - Investing.com India
Citadel discloses 1.31% stake in Mural Oncology By Investing.com - Investing.com Canada
What candlestick patterns are forming on Mural Oncology plcJuly 2025 Trade Ideas & Daily Stock Momentum Reports - newser.com
Is Mural Oncology plc a candidate for recovery playJuly 2025 Trade Ideas & Entry Point Confirmation Signals - newser.com
Citadel Group discloses 1.3% stake in Mural Oncology By Investing.com - Investing.com South Africa
Citadel Group discloses 1.3% stake in Mural Oncology - Investing.com India
Why Mural Oncology plc stock is favored by pension fundsWeekly Trade Recap & Daily Profit Maximizing Trade Tips - newser.com
Citadel Group discloses 1.26% stake in Mural Oncology By Investing.com - Investing.com Canada
Citadel Group discloses 1.26% stake in Mural Oncology - Investing.com India
Is it too late to sell Mural Oncology plcPortfolio Profit Report & Community Supported Trade Ideas - newser.com
How Mural Oncology plc stock performs during Fed tightening cyclesPortfolio Growth Summary & Advanced Swing Trade Entry Alerts - newser.com
Combining price and volume data for Mural Oncology plc - newser.com
Is Mural Oncology plc stock attractive for growth ETFsEarnings Risk Report & Detailed Earnings Play Strategies - newser.com
Citadel Group discloses 1.23% stake in Mural Oncology By Investing.com - Investing.com Australia
Citadel Group discloses 1.23% stake in Mural Oncology - Investing.com
Mural Oncology plc Stock Analysis and ForecastPrice Action Trading & Discover Top Gainers in Every Sector - earlytimes.in
What analysts say about Mural Oncology plc stockSector Rotation Strategies & Get The Analyst Consensus With One Click - earlytimes.in
Mural Oncology Plc (MURA) 재무 분석
Mural Oncology Plc (MURA)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Mural Oncology Plc 주식 (MURA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Goodman Vicki L | Chief Medical Officer |
Nov 10 '25 |
Sale |
2.08 |
5,036 |
10,475 |
84,727 |
0.53%
1.88%
자본화:
|
볼륨(24시간):